Latest News for: ogn

Edit

Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

The Call 12 Feb 2026
OGN) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 5.3% year on year to $1.51 billion ... Organon (OGN) Q4 CY2025 Highlights. ... OGN) is a global healthcare company focused on ...
Edit

Organon Earnings: What To Look For From OGN

The Call 11 Feb 2026
Pharmaceutical company Organon (NYSE. OGN) will be announcing earnings results this Thursday morning. Here’s what you need to know ... Is Organon a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... More News ... .
Edit

Why Are Organon (OGN) Shares Soaring Today

The Call 20 Jan 2026
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) jumped 8.9% in the afternoon session after reports surfaced that Sun Pharmaceutical Industries submitted a non-binding proposal to acquire the company ... More News. View More ... Tickers ATO.
Edit

Why Organon (OGN) Shares Are Trading Lower Today

The Call 09 Dec 2025
What Happened?. Shares of pharmaceutical company Organon (NYSE. OGN) fell 4.7% in the afternoon session after Barclays initiated coverage on the company with an 'Underweight' rating and a price target of $7.50 ... More News. View More ... Via MarketBeat ... .
Edit

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?

The Call 01 Dec 2025
Over the past six months, Organon’s stock price fell to $7.77 ... This may have investors wondering how to approach the situation ... Why Is Organon Not Exciting? ... Here are three reasons there are better opportunities than OGN and a stock we'd rather own. 1 ... 2.
  • 1

Article Search

tools
×
×
×
×